60
Participants
Start Date
June 18, 2018
Primary Completion Date
July 6, 2018
Study Completion Date
July 6, 2018
Cisticid
Participants received single oral dose of 1200 mg (two 600 mg tablets) Cisticid (Test) on Day 1 (Treatment Period 1) or Day 8 (Treatment Period 2) or Day 15 (Treatment Period 3).
Biltricide
Participants received 600 mg of Biltricide (Reference) tablet at a dose of 1200 mg on either Day 1 (Treatment Period 1) or Day 8 (Treatment Period 2).
Clínica de Enfermedades Crónicas y de Procedimientos Especiales, Sociedad Civil (SC), México
Merck KGaA, Darmstadt, Germany
INDUSTRY